Company · CIK 1738021
Compass Therapeutics, Inc.
| CIK | 1738021 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2836 — Biological Products, (No Diagnostic Substances) |
| Incorporated in | DE |
| Business address | MA |
| Listed | CMPX (Nasdaq) |
| First annual or quarterly report | 2018-08-14 |
Offerings
6 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-292491 | 2025-12-30 | 2026-01-07 | 2 | |
| 333-281891 | 2024-08-30 | 2025-08-13 | 4 | |
| 333-268652 | 2022-12-02 | 2023-01-20 | 2 | |
| 333-257821 | 2021-07-09 | 2022-08-01 | 7 | |
| 333-244353 | 2020-08-11 | 2021-03-08 | 4 | |
| 333-249536 | 2020-10-19 | 2020-11-13 | 3 |
Filings
23| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2026-01-07 | EFFECTDeclared effective | 333-292491 | 9999999995-26-000102 |
| 2025-12-30 | S-3Shelf registered | 333-292491 | 0001193125-25-337063 |
| 2025-08-13 | 424B5Shelf takedown | 333-281891 | 0001193125-25-179955 |
| 2025-08-12 | 424B5Shelf takedown | 333-281891 | 0001193125-25-178973 |
| 2024-09-06 | EFFECTDeclared effective | 333-281891 | 9999999995-24-002748 |
| 2024-08-30 | S-3Shelf registered | 333-281891 | 0001193125-24-211242 |
| 2023-01-20 | EFFECTDeclared effective | 333-268652 | 9999999995-23-000145 |
| 2022-12-02 | S-3Shelf registered | 333-268652 | 0001171843-22-007790 |
| 2022-08-01 | 424B5Shelf takedown | 333-257821 | 0001193125-22-207846 |
| 2021-12-15 | 424B5Shelf takedown | 333-257821 | 0001193125-21-357498 |
| 2021-12-15 | 424B5Shelf takedown | 333-257821 | 0001193125-21-357496 |
| 2021-11-03 | 424B5Shelf takedown | 333-257821 | 0001193125-21-318640 |
| 2021-11-01 | 424B5Shelf takedown | 333-257821 | 0001193125-21-315459 |
| 2021-07-20 | EFFECTDeclared effective | 333-257821 | 9999999995-21-002847 |
| 2021-07-09 | S-3Shelf registered | 333-257821 | 0001193125-21-212011 |
| 2021-03-08 | EFFECTDeclared effective | 333-244353 | 9999999995-21-000858 |
| 2020-11-13 | RWWithdrawn | 333-249536 | 0001193125-20-293162 |
| 2020-11-09 | S-1/AAmendment | 333-249536 | 0001193125-20-288526 |
| 2020-10-19 | S-1Registration filed | 333-249536 | 0001193125-20-271775 |
| 2020-09-25 | EFFECTDeclared effective | 333-244353 | 9999999995-20-002580 |
| 2020-09-23 | DRSDraft made public | 377-03585 | 0000950123-20-009900 |
| 2020-09-18 | S-1/AAmendment | 333-244353 | 0001193125-20-249227 |
| 2020-08-11 | S-1Registration filed | 333-244353 | 0001193125-20-216242 |